{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:25:33Z","timestamp":1790126733113,"version":"4.0.1"},"reference-count":31,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1536\/ihj.17-555","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T18:37:37Z","timestamp":1535481457000},"page":"1015-1025","source":"Crossref","is-referenced-by-count":23,"title":["Safety, Tolerability, and Pharmacokinetics of NK-104-NP"],"prefix":"10.1536","volume":"59","author":[{"given":"Kaku","family":"Nakano","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Research, Development, and Translational Medicine, Center for Disruptive Cardiovascular Medicine, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichiro","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Research, Development, and Translational Medicine, Center for Disruptive Cardiovascular Medicine, Kyushu University"},{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Kashihara","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Fukae","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Ieiri","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacokinetics, Graduate School of Pharmaceutical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Shiramoto","sequence":"additional","affiliation":[{"name":"Souseikai Hakata Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Irie","sequence":"additional","affiliation":[{"name":"Souseikai Hakata Clinic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Center for Clinical and Translational Research, Kyushu University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Todaka","sequence":"additional","affiliation":[{"name":"Center for Clinical and Translational Research, Kyushu University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Egashira","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Research, Development, and Translational Medicine, Center for Disruptive Cardiovascular Medicine, Kyushu University"},{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pietra GG, Capron F, Stewart S, <i>et al<\/i>. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004; 43: 25S-32S.","DOI":"10.1016\/j.jacc.2004.02.033"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tuder RM, Abman SH, Braun T, <i>et al<\/i>. Development and pathology of pulmonary hypertension. J Am Coll Cardiol 2009; 54: S3-9.","DOI":"10.1016\/j.jacc.2009.04.009"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. D&apos;Alonzo GE, Barst RJ, Ayres SM, <i>et al<\/i>. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-9.","DOI":"10.7326\/0003-4819-115-5-343"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. McLaughlin VV, Suissa S. Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases. Circulation 2010; 122: 106-8.","DOI":"10.1161\/CIRCULATIONAHA.110.963983"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shapiro SM, Oudiz RJ, Cao T, <i>et al<\/i>. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol 1997; 30: 343-9.","DOI":"10.1016\/S0735-1097(97)00187-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sitbon O, Humbert M, Nunes H, <i>et al<\/i>. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-8.","DOI":"10.1016\/S0735-1097(02)02012-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Barst RJ, Rubin LJ, McGoon MD, Caldwell EJ, Long WA, Levy PS. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin. Ann Intern Med 1994; 121: 409-15.","DOI":"10.7326\/0003-4819-121-6-199409150-00003"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest 2012; 142: 448-56.","DOI":"10.1378\/chest.11-1460"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Savai R, Pullamsetti SS, Kolbe J, <i>et al<\/i>. Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2012; 186: 897-908.","DOI":"10.1164\/rccm.201202-0335OC"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ikeda Y, Yonemitsu Y, Kataoka C, <i>et al<\/i>. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats. Am J Physiol Heart Circ Physiol 2002; 283: H2021-8.","DOI":"10.1152\/ajpheart.00919.2001"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Kimura S, Egashira K, Chen L, <i>et al<\/i>. Nanoparticle-mediated delivery of nuclear factor kappaB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension. Hypertension 2009; 53: 877-83.","DOI":"10.1161\/HYPERTENSIONAHA.108.121418"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Chen L, Nakano K, Kimura S, <i>et al<\/i>. Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension. Hypertension 2011; 57: 343-50.","DOI":"10.1161\/HYPERTENSIONAHA.110.157032"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Klinger JR, Abman SH, Gladwin MT. Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension. Am J Respir Crit Care Med 2013; 188: 639-46.","DOI":"10.1164\/rccm.201304-0686PP"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sugita T, Hyers TM, Dauber IM, Wagner WW, McMurtry IF, Reeves JT. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J Appl Physiol Respir Environ Exerc Physiol 1983; 54: 371-4.","DOI":"10.1152\/jappl.1983.54.2.371"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 2001; 21: 1712-9.","DOI":"10.1161\/hq1101.098486"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Girgis RE, Mozammel S, Champion HC, <i>et al<\/i>. Regression of chronic hypoxic pulmonary hypertension by simvastatin. Am J Physiol Lung Cell Mol Physiol 2007; 292: L1105-10.","DOI":"10.1152\/ajplung.00411.2006"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Nishimura T, Vaszar LT, Faul JL, <i>et al<\/i>. Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells. Circulation 2003; 108: 1640-5.","DOI":"10.1161\/01.CIR.0000087592.47401.37"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wong MJ, Kantores C, Ivanovska J, Jain A, Jankov RP. Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling. Am J Physiol Lung Cell Mol Physiol 2016; 311: L985-99.","DOI":"10.1152\/ajplung.00345.2016"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kawut SM, Lima JA, Barr RG, <i>et al<\/i>. Sex and race differences in right ventricular structure and function: the multi-ethnic study of atherosclerosis-right ventricle study. Circulation 2011; 123: 2542-51.","DOI":"10.1161\/CIRCULATIONAHA.110.985515"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Zeng WJ, Xiong CM, Zhao L, <i>et al<\/i>. Atorvastatin in pulmonary arterial hypertension (APATH) study. Eur Respir J 2012; 40: 67-74.","DOI":"10.1183\/09031936.00149011"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nagahama R, Matoba T, Nakano K, Kim-Mitsuyama S, Sunagawa K, Egashira K. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia. Arterioscler Thromb Vasc Biol 2012; 32: 2427-34.","DOI":"10.1161\/ATVBAHA.112.253823"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Oda S, Nagahama R, Nakano K, <i>et al<\/i>. Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia. J Vasc Surg 2010; 52: 412-20.","DOI":"10.1016\/j.jvs.2010.03.020"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nagaoka K, Matoba T, Mao Y, <i>et al<\/i>. A new therapeutic modality for acute myocardial infarction: nanoparticle-mediated delivery of pitavastatin induces cardioprotection from ischemia-reperfusion injury via activation of PI3K\/Akt pathway and anti-inflammation in a rat model. PLOS ONE 2015; 10: e0132451.","DOI":"10.1371\/journal.pone.0132451"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ichimura K, Matoba T, Nakano K, <i>et al<\/i>. A translational study of a new therapeutic approach for acute myocardial infarction: nanoparticle-mediated delivery of pitavastatin into reperfused myocardium reduces ischemia-reperfusion injury in a preclinical porcine model. PLOS ONE 2016; 11: e0162425.","DOI":"10.1371\/journal.pone.0162425"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Mao Y, Koga JI, Tokutome M, <i>et al<\/i>. Nanoparticle-mediated delivery of pitavastatin to monocytes\/macrophages inhibits left ventricular remodeling after acute myocardial infarction by inhibiting monocyte-mediated inflammation. Int Heart J 2017; 58: 615-23.","DOI":"10.1536\/ihj.16-457"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Katsuki S, Matoba T, Nakashiro S, <i>et al<\/i>. Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization\/rupture in mice by regulating the recruitment of inflammatory monocytes. Circulation 2014; 129: 896-906.","DOI":"10.1161\/CIRCULATIONAHA.113.002870"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Savic RM, Karlsson MO. Evaluation of an extended grid method for estimation using nonparametric distributions. AAPS J 2009; 11: 615-27.","DOI":"10.1208\/s12248-009-9138-8"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Qi X, Ding L, Wen A, Zhou N, Du X, Shakya S. Simple LC-MS\/MS methods for simultaneous determination of pitavastatin and its lactone metabolite in human plasma and urine involving a procedure for inhibiting the conversion of pitavastatin lactone to pitavastatin in plasma and its application to a pharmacokinetic study. J Pharm Biomed Anal 2013; 72: 8-15.","DOI":"10.1016\/j.jpba.2012.09.026"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Nakano Y, Matoba T, Tokutome M, <i>et al<\/i>. Nanoparticle-mediated delivery of irbesartan induces cardioprotection from myocardial ischemia-reperfusion injury by antagonizing monocyte-mediated inflammation. Sci Rep 2016; 6: 29601.","DOI":"10.1038\/srep29601"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ikeda G, Matoba T, Nakano Y, <i>et al<\/i>. Nanoparticle-mediated targeting of cyclosporine A enhances cardioprotection against ischemia-reperfusion injury through inhibition of mitochondrial permeability transition pore opening. Sci Rep 2016; 6: 20467.","DOI":"10.1038\/srep20467"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ishikita A, Matoba T, Ikeda G, <i>et al<\/i>. Nanoparticle-mediated delivery of mitochondrial division Inhibitor 1 to the myocardium protects the heart from ischemia-reperfusion injury through inhibition of mitochondria outer membrane permeabilization: A new therapeutic modality for acute myocardial infarction. J Am Heart Assoc 2016; 5.","DOI":"10.1161\/JAHA.116.003872"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/5\/59_17-555\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T01:04:02Z","timestamp":1538183042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/5\/59_17-555\/_article"}},"subtitle":["A Multicenter, Randomized, Placebo-Controlled Phase I Investigator-Initiated Trial for Intravenous Administration of Pitavastatin-Loaded PLGA Nanoparticles (NK-104-NP) in Healthy Japanese Male Subjects"],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.17-555","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}